• Kirin management briefed investors on its Aug. 7, 2026 plan to buy Jamieson Wellness, entering North America for Health Science growth.
• Transaction targets 100% ownership via a Canadian Plan of Arrangement, with closing expected in Q4 2026 pending shareholder, court, regulatory clearances.
• Offer price set at CAD 45.75 per share, valuing the deal at CAD 1.9 billion, or JPY 218.3 billion at CAD 1 = JPY 115.
• Funding to come from cash on hand, cash equivalents, interest-bearing debt; EPS expected to turn positive from fiscal 2027.
• Strategic focus on combining Kirin ingredients and Asia-Oceania platform with Jamieson’s North American brand to expand sales networks and R&D.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kirin Holdings Company Limited published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.